多中心卡斯特曼病的细胞因子风暴
1Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Philadelphia, PA, USA. davidfa@pennmedicine.upenn.edu.
Advances in experimental medicine and biology
|August 8, 2024
概括
细胞因子风暴疾病,如多中心卡斯特曼病 (MCD),共享症状,并可以有各种触发因素. 用托西利祖马布向介质素-6 (IL-6) 有效治疗异常性MCD (iMCD).
科学领域:
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 细胞因子风暴疾病具有重叠的临床特征,可以由各种因素引发.
- 多中心卡斯特曼病 (MCD) 是一个例子,其中的原因包括病毒感染,瘤细胞或异常起源.
- 异形性MCD (iMCD) 是对向治疗有反应的细胞因子风暴疾病的一个关键例子.
研究的目的:
- 突出细胞因子风暴疾病的各种触发因素和共同特征.
- 将IMCD作为向细胞因子抑制治疗的模型.
- 讨论托西利祖马布在细胞因子风暴管理中的历史和持续使用.
主要方法:
- 审查细胞因子风暴疾病的临床特征和触发因素.
- 对异形性MCD (iMCD) 治疗的案例研究分析.
- 药理学审查对抗类素-6 (IL-6) 受体单克隆抗体治疗.
主要成果:
- 多个触发因素可以诱导类似的细胞因子风暴综合征,包括MCD.
- 用托西利祖马布向性中和interleukin-6 (IL-6) 在治疗iMCD时显示出有效性.
- 托西利祖马布已经在各种细胞因子风暴环境中使用了30多年.
结论:
- 细胞因子风暴障碍是复杂的,尽管有不同的病因,但通常具有共同的临床表现.
- 针对性细胞因子抑制,以抗IL-6治疗iMCD为例,代表了管理这些疾病的重大进展.
- 托西利祖马布的长期应用强调了它在治疗细胞因子介导的炎症性疾病中的作用.
更多相关视频
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
560
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.3K
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
